Levy Konigsberg Sues Kenvue in 116 Mesothelioma Johnson's Baby Powder Lawsuits
NEW YORK, June 15, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has sued J&J's new consumer health spin-off, Kenvue, in 116 Johnson's Baby Powder mesothelioma cases. Kenvue was initially listed in May in the New York Stock Exchange (KVUE) as part of an initial public offering (IPO) at a $22 per share price. The stock price has since risen to over $25 per share, giving the new consumer health company a market cap of over 48 billion.
- Levy Konigsberg has filed 116 mesothelioma cases against J&J's new consumer health spin-off, Kenvue (NYSE: KVUE)
NEW YORK, June 15, 2023 /PRNewswire/ -- Levy Konigsberg, a leading national law firm representing victims of corporate misconduct, has sued J&J's new consumer health spin-off, Kenvue, in 116 Johnson's Baby Powder mesothelioma cases. - Kenvue owns the Johnson's Baby product lines, which include well-known products such as Johnson's Baby Powder and Johnson's Baby Shampoo.
- Kenvue is now profiting from the Johnson's Baby Powder business and is liable, along with Johnson & Johnson, under well-established New Jersey law."
- Levy Konigsberg LLP has been representing victims of mesothelioma in civil lawsuits since 1985.